The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Wide Variability in Medication Adherence among Patients with Atrial Fibrillation
Research indicates that, despite the relative simplicity of dabigatran regimens, physicians and pharmacists must follow up with patients repeatedly to maximize the chances they'll adhere to prescriptions.
Diabetes Drug Addresses Inflammation in HIV Patients
May 22nd 2015Sitagliptin appears to have beneficial systemic and adipose anti-inflammatory effects in combination antiretroviral therapy-treated HIV-positive adults with impaired glucose tolerance. The drug may prevent cardiovascular problems by reducing inflammation linked to heart disease and stroke in this patient population.
Antipsychotics Safe for Pregnant Women
May 21st 2015The results of the largest study of its kind to date indicate that new antipsychotic medications-including quetiapine, olanzapine, and risperidone-do not appear to put women at additional risk of developing gestational diabetes, hypertensive disorders, or major blood clots that obstruct circulation, all conditions that often develop during pregnancy or with the use of older antipsychotic medications.
The Parable of the Salt and the Evolving Medical Consensus
May 21st 2015Changes in the way we think about sodium intake and cardiovascular risk, calcium supplementation, and other topics should remind us all of the advice we heard on the first day of medical school: 50% of what you learn here is wrong or going to disappear over your career; we just don't know which 50%.
More than 13,000 physicians and cardiovascular team members attended the ACC 2015 meeting in San Diego on March 14-16, 2015. In this issue of Cardiology Review, we focus on 6 important studies presented at ACC 2015: LEGACY, OSLER, PEGASUS, EMBRACE-STEMI, MATRIX, and CoreValve.
Sepsis Readmissions Bigger Problem than Thought
Hospitals have been paying Medicare penalties when patients are readmitted too soon after discharge. So far the focus has been on patients with heart failure and pneumonia but a study from NYU finds sepsis readmissions are also common.
Antithrombotic Therapy in Patients with Atrial Fibrillation and Chronic Kidney Disease
May 14th 2015The presence of chronic kidney disease (CKD) in patients with atrial fibrillation increases the risk of stroke and thromboembolism (TE) as well as the risk of bleeding, thus complicating their treatment. In this context, it has been suggested that CKD should be included in the CHA2DS2-VASc (Congestive heart failure; Hypertension; Age ≥75 years; Diabetes mellitus; previous Stroke, transient ischemic attack, or thromboembolism; Vascular disease; Age 65 to 74 years; Sex category) score.
Surgical Treatment of Moderate Ischemic Mitral Regurgitation
May 14th 2015The addition of a mitral valve repair to patients undergoing coronary artery bypass graft (CABG) surgery with moderate ischemic mitral regurgitation is still a source of controversy. Recent guidelines state that concomitant mitral valve repair at the time of CABG may be beneficial, but the evidence is inconclusive.
Novel Treatment for Refractory Angina Using a Coronary Sinus Reducer Device: A Glimmer of Hope
May 14th 2015Refractory angina is a loosely defined term generally referring to the persistence of life-impacting angina despite maximal antianginal medications and, when possible, coronary revascularization (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]). Numerous novel pharmacotherapies and mechanical interventions have been proposed, and studies conducted, to treat patients with refractory angina.
Efficacy of Beta-Blockers in Patients with Heart Failure Plus Atrial Fibrillation
May 14th 2015Atrial fibrillation (AF) and heart failure (HF) often coexist. The use of beta-blockers in HF patients has a class 1A recommendation in both the European and American guidelines. In current guidelines for heart failure therapy, the recommendation for beta-blockers is not restricted to patients with sinus rhythm, and includes all HF patients.
Intra-Arterial Treatment for Acute Ischemic Stroke
May 14th 2015The primary objectives of treating acute ischemic stroke are to prevent death and limit functional disability. Similar to acute myocardial infarction (AMI), timely reperfusion using systemic thrombolysis has been shown to improve outcome of acute stroke, namely functional neurologic recovery, but not mortality. But unlike AMI, the role of intra-arterial or endovascular therapy in acute stroke has not been clearly established.
Pay-for-Performance in Diabetes: Sorting the Good from the Not-so-Good
May 12th 2015As P4P strategies gain popularity, the need for accurate assessment tools becomes more and more apparent-many physicians support PCP but believe that current measures are inaccurate. A common problem is that physicians appear to be penalized if they treat the elderly or patients who have reduced access to care or drug treatment.
Atrial Fibrillation Increases Heart Attack Risk
Analysis of a large patient cohort indicates that atrial fibrillation is associated with an increased risk of just 1 of the 2 major types of heart attack - but the association is strong enough to increase the overall heart-attack risk by 63%.